-
Ravdin and colleagues from the University of Texas M.D. Anderson Cancer Center reported a 7% decrease (14,000 fewer cases) in the incidence of breast cancer in 9 regions of the U.S. in 2003.
-
Herbal Supplements to Treat Vasomotor Symptoms; Bisphosphonates to Treat LBD, After 5 Years?; FDA Actions
-
The investigators enticed 14 male surgeons and 16 male physicians (internal medicine and sub-specialists) to submit recent photographs of themselves to the investigators and to indicate how tall they were.
-
The lead paper in the November issue of Obstetrics and Gynecology should stimulate lively discussion regarding the counseling of patients of advanced maternal age (AMA), and, if taken at face value, could impact the field of prenatal diagnosis, in general.
-
The resection of tumor nodules (or cytoreduction) before primary chemotherapy has been linked closely with survival in patients with advanced epithelial ovarian cancer. Chi and colleagues set out to evaluate the merits of cytoreduction completeness in a homogeneous cohort of ovarian cancer patients with bulky metastatic disease.
-
Kahlenborn and colleagues performed a meta-analysis of case-control studies published after 1979 that focused on the use of oral contraceptives and the risk of premenopausal breast cancer.
-
-
Drug Labels A Prescription for Misunderstanding?; Osteonecrosis of the Jaw New Side-Effect to Bisphosphate Use; Beta-Blockers and Depression Unlinked?; FDA Actions
-
Lacey and colleagues from the National Cancer Institute reported the results of postmenopausal hormone exposure in a cohort study with 214 cases of ovarian cancer.1 The over-all cohort of 97,368 women constituted the NIH-AARP Diet and Health Study.
-
The Institute of Women's Health and Integrative Medicine is offering a seminar on Women's Cancers in Portland, OR, on Jan. 26-28.